COVID-19: After Lilly, Regeneron Bags EUA for its Antibody Therapy
On November 21st, the F.D.A issued an emergency use authorization (EUA) for Regeneron Pharmaceuticals Inc.’s COVID-19 antibody cocktail therapy and became the first in the United States or Europe to …
Read More